G&E Herbal Biotechnology Co., Ltd. (4911.TWO)
TWD 57.1
(-0.7%)
TWD 57.1
(-0.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 113.48 Million | 99.96 Million | -9.19 Million | 771 Thousand | - |
| Net Income | 90.5 Million | 7.22 Million | -18.22 Million | -13.05 Million | - |
| Depreciation & Amortization | 9.33 Million | 9.39 Million | 9.33 Million | 9.21 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 13.76 Million | 82.46 Million | -324 Thousand | 8.36 Million | - |
| Other non-cash items | -4.39 Million | 263 Thousand | -517 Thousand | -4.35 Million | - |
| Investing Cash Flow | -88.43 Million | 2.5 Million | 7.01 Million | 9.12 Million | - |
| Investments in PPE | -5.51 Million | -2.96 Million | -1.98 Million | -6.76 Million | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -82.04 Million | - | - | 15.9 Million | 18.5 Million |
| Sales/Maturities of investments | - | 5.4 Million | 9 Million | 15.9 Million | - |
| Other Investing Activities | -872 Thousand | 72 Thousand | - | -5000.00 | 19 Thousand |
| Financing Cash Flow | -116 Thousand | - | - | - | -786 Thousand |
| Debt repayment | -2.93 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -116 Thousand | - | - | - | -786 Thousand |
| Accounts receivables | -14.03 Million | - | - | - | - |
| Accounts payables | -2 Million | - | - | - | - |
| Inventory | 1.74 Million | -5.68 Million | -2.84 Million | 141 Thousand | - |
| Other working capital | 26.05 Million | - | - | - | - |
| Cash at beginning of period | 114.74 Million | 12.28 Million | 14.45 Million | 4.56 Million | - |
| Cash at end of period | 139.68 Million | 114.74 Million | 12.28 Million | 14.45 Million | -786 Thousand |
| Capital Expenditure | -5.51 Million | -2.96 Million | -1.98 Million | -6.76 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 24.93 Million | 102.46 Million | -2.17 Million | 9.89 Million | -786 Thousand |
| Free Cash Flow | 107.96 Million | 96.99 Million | -11.17 Million | -5.99 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 29.43 Million | 24.55 Million | 23.02 Million | 90.5 Million | 27.78 Million | 20.86 Million |
| Depreciation & Amortization | 2.58 Million | 2.57 Million | 2.43 Million | 9.33 Million | 2.28 Million | 2.28 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -28.39 Million | -17.2 Million | 76.22 Million | 13.76 Million | -12 Million | -20 Million |
| Other non-cash items | -1.25 Million | -863 Thousand | -795 Thousand | -4.39 Million | -2.6 Million | -639 Thousand |
| Investing Cash Flow | -530 Thousand | -84.39 Million | -2.77 Million | -88.43 Million | -14.8 Million | 5.33 Million |
| Investments in PPE | -360 Thousand | -1.34 Million | -1.89 Million | -5.51 Million | -307 Thousand | 20 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -83.04 Million | - | -82.04 Million | -14.5 Million | 5.3 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -170 Thousand | - | -880 Thousand | -872 Thousand | - | 11 Thousand |
| Financing Cash Flow | -171 Thousand | -171 Thousand | - | -116 Thousand | - | - |
| Debt repayment | -2.45 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -171 Thousand | - | - | - | - | - |
| Accounts receivables | -506 Thousand | - | - | - | - | - |
| Accounts payables | 361 Thousand | - | - | - | - | - |
| Inventory | -72 Thousand | 2.46 Million | 1.24 Million | 1.74 Million | 160 Thousand | 55 Thousand |
| Other working capital | -30.63 Million | - | - | - | - | - |
| Cash at beginning of period | 64.95 Million | 139.68 Million | 41 Million | 114.74 Million | 37.66 Million | 29.21 Million |
| Cash at end of period | 67.84 Million | 64.95 Million | 139.68 Million | 139.68 Million | 41 Million | 37.66 Million |
| Capital Expenditure | -360 Thousand | -1.34 Million | -1.89 Million | -5.51 Million | -307 Thousand | 20 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2.88 Million | -74.73 Million | 98.67 Million | 24.93 Million | 3.34 Million | 8.44 Million |
| Free Cash Flow | 3.23 Million | 8.48 Million | 99.67 Million | 107.96 Million | 17.84 Million | 3.13 Million |
0M2A
PRQ
601226
688285
8153
9024